About this item:

187 Views | 167 Downloads

Author Notes:

Correspondence to: Jennifer G. Mulle, MHS, PhD, Rollins School of Public Health, Emory University, Claudia Nance Rollins, Room 4053, 1518 Clifton Rd, Atlanta GA 30322, (404) 727-3042, jmulle@emory.edu

Contributions: T. R., J.S., and G.G. were the main authors of the review.

S.W. advised on projects that contributed to the content of this review.

D.W. edited and revised the molecular and behavior content of the review.

T.C. edited and revised the genetic content of the review.

J.M. edited and revised the clinical and medical content of the review.

J.M. generated Figure 1; T.R. generated Figures 2 and ​and33 with assistance from T.C.

Conflict of Interest: The authors have nothing to disclose.

Subjects:

Research Funding:

The authors would like to thank Sarah Bay and Cheryl Timms Strauss for editing and the NIGMS for funding (R01 GM097331).

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Neurosciences
  • Neurosciences & Neurology
  • CNVs
  • genetics
  • schizophrenia
  • CRISPR
  • behavioral assays
  • 3Q29 MICRODELETION SYNDROME
  • AUTISM SPECTRUM DISORDERS
  • 22Q11.2 DELETION SYNDROME
  • DIGEORGE-SYNDROME REGION
  • LATENT INHIBITION MODEL
  • PLURIPOTENT STEM-CELLS
  • ZINC-FINGER NUCLEASES
  • REACTION-TIME-TASK
  • CHROMOSOMAL REARRANGEMENTS
  • INTELLECTUAL DISABILITY

Unraveling the genetic architecture of copy number variants associated with schizophrenia and other neuropsychiatric disorders

Tools:

Journal Title:

Journal of Neuroscience Research

Volume:

Volume 95, Number 5

Publisher:

, Pages 1144-1160

Type of Work:

Article | Post-print: After Peer Review

Abstract:

Recent studies show that the complex genetic architecture of schizophrenia (SZ) is driven in part by polygenic components, or the cumulative effect of variants of small effect in many genes, as well as rare single-locus variants with large effect sizes. Here we discuss genetic aberrations known as copy number variants (CNVs), which fall in the latter category and are associated with a high risk for SZ and other neuropsychiatric disorders. We briefly review recurrent CNVs associated with SZ, and then highlight one CNV in particular, a recurrent 1.6-Mb deletion on chromosome 3q29, which is estimated to confer a 40-fold increased risk for SZ. Additionally, we describe the use of genetic mouse models, behavioral tools, and patient-derived induced pluripotent stem cells as a means to study CNVs in the hope of gaining mechanistic insight into their respective disorders. Taken together, the genomic data connecting CNVs with a multitude of human neuropsychiatric disease, our current technical ability to model such chromosomal anomalies in mouse, and the existence of precise behavioral measures of endophenotypes argue that the time is ripe for systematic dissection of the genetic mechanisms underlying such disease.

Copyright information:

© 2016 Wiley Periodicals, Inc.

Export to EndNote